Propanc Biopharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Propanc Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q3 2024.
  • Propanc Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$354K, a 0.98% decline year-over-year.
  • Propanc Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$1.82M, a 23.8% increase year-over-year.
  • Propanc Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$1.82M, a 31.6% increase from 2023.
  • Propanc Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$2.66M, a 0.09% decline from 2022.
  • Propanc Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.66M, a 31.2% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.82M -$354K -$3.44K -0.98% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$1.82M -$359K +$389K +52.1% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-30
Q1 2024 -$2.21M -$527K +$283K +35% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$2.49M -$584K -$99K -20.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$2.39M -$351K +$266K +43.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$2.66M -$748K +$157K +17.3% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 -$2.82M -$810K -$347K -75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$2.47M -$485K +$315K +39.3% Oct 1, 2022 Dec 31, 2022 10-Q 2024-05-15
Q3 2022 -$2.78M -$617K -$127K -25.8% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-15
Q2 2022 -$2.66M -$905K -$126K -16.1% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 -$2.53M -$463K -$44.9K -10.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2.49M -$800K -$396K -98.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-05-15
Q3 2021 -$2.09M -$491K -$65.1K -15.3% Jul 1, 2021 Sep 30, 2021 10-Q 2023-05-15
Q2 2021 -$2.03M -$779K -$1.98M -165% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 -$42.9K -$418K +$2.17M +83.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$2.21M -$404K +$1.46M +78.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-05-16
Q3 2020 -$3.67M -$426K +$1.07M +71.5% Jul 1, 2020 Sep 30, 2020 10-Q 2022-05-16
Q2 2020 -$4.74M $1.2M +$2.81M Apr 1, 2020 Jun 30, 2020 10-K 2021-09-28
Q1 2020 -$7.55M -$2.59M -$2M -344% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$5.54M -$1.87M -$417K -28.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-05-14
Q3 2019 -$5.13M -$1.49M +$633K +29.8% Jul 1, 2019 Sep 30, 2019 10-Q 2021-05-14
Q2 2019 -$5.76M -$1.6M -$179K -12.6% Apr 1, 2019 Jun 30, 2019 10-K 2020-10-01
Q1 2019 -$5.58M -$582K +$909K +61% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$6.49M -$1.45M +$752K +34.1% Oct 1, 2018 Dec 31, 2018 10-Q 2020-05-15
Q3 2018 -$7.24M -$2.12M -$201K -10.5% Jul 1, 2018 Sep 30, 2018 10-Q 2020-05-15
Q2 2018 -$7.04M -$1.42M +$211K +12.9% Apr 1, 2018 Jun 30, 2018 10-K 2019-10-15
Q1 2018 -$7.25M -$1.49M -$120K -8.74% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$7.13M -$2.2M +$1.56M +41.5% Oct 1, 2017 Dec 31, 2017 10-Q 2019-05-15
Q3 2017 -$8.69M -$1.92M -$822K -74.6% Jul 1, 2017 Sep 30, 2017 10-Q 2019-05-15
Q2 2017 -$7.87M -$1.63M +$1.22M +42.8% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-17
Q1 2017 -$9.09M -$1.37M +$781K +36.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$9.87M -$3.76M -$199K -5.58% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 -$9.67M -$1.1M -$263K -31.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$9.41M -$2.86M -$1.03M -56.2% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 -$8.38M -$2.15M -$1.7M -374% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$6.68M -$3.56M -$3.22M -931% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$3.47M -$839K -$55.6K -7.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$3.41M -$1.83M -$1.61M -741% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-28
Q1 2015 -$1.8M -$454K -$387K -579% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$1.41M -$345K -$372K -1409% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 -$1.04M -$783K -$212K -37.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$830K -$218K +$6.95K +3.09% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-30
Q1 2014 -$837K -$66.9K +$271K +80.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$1.11M $26.4K +$414K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$1.52M -$572K -$78.8K -16% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 -$1.44M -$225K +$2.33M +91.2% Apr 1, 2013 Jun 30, 2013 10-K 2014-10-14
Q1 2013 -$3.77M -$338K +$2.76M +89.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$6.53M -$388K +$2.32M +85.7% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$8.85M -$493K +$2.58M +84% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$11.4M -$2.55M Apr 1, 2012 Jun 30, 2012 10-K 2013-10-15
Q1 2012 -$3.1M -$2.59M -509% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 -$2.71M -$2.3M -559% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-20
Q3 2011 -$3.07M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q1 2011 -$508K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$411K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.